Study identifies new therapeutic target in Non-Hodgkin’s Lymphoma
Researchers have discovered that an enzyme called uracil-DNA glycosylase (UNG) protects the ends of B cell chromosomes to facilitate the proliferation of these antibody-producing cells in response to infection. The study also suggests that targeting this enzyme may help treat certain types of non-Hodgkin’s lymphoma.
Leave a Reply